Vaxrank statistics

To access cutting-edge analytics on consensus tools, life science contexts and associated fields, you will need to subscribe to our premium service.


Citations per year

Citations chart

Popular tool citations

chevron_left Vaccine candidate prediction chevron_right
Popular tools chart

Tool usage distribution map

Tool usage distribution map

Associated diseases

Associated diseases

Vaxrank specifications


Unique identifier OMICS_18658
Name Vaxrank
Software type Package/Module
Interface Command line interface
Restrictions to use None
Input data One or more files containing somatic variants, aligned tumor RNA-seq reads, and the HLA alleles to be used for MHC binding prediction.
Input format VCF, MAF, JSON, BAM
Operating system Unix/Linux
Programming languages Python
License Apache License version 2.0
Computer skills Advanced
Stability Stable
Maintained Yes



Add your version


  • person_outline Alexander Rubinsteyn <>

Publication for Vaxrank


Vaxrank: A Computational Tool For Designing Personalized Cancer Vaccines.

2017 BioRxiv
DOI: 10.1101/142919
Alex Rubinsteyn
Alex Rubinsteyn
Alex Rubinsteyn
Alex Rubinsteyn

Vaxrank in publication

PMCID: 5778604
PMID: 29403468
DOI: 10.3389/fimmu.2017.01807

[…] mutation abundance, predict mhc ligands overlapping mutations, and finally to generate a ranked list of candidate vaccine peptides., some of the tools used in vaccine peptide selection include: vaxrank (): overall vaccine selection tool with ranking logic.isovar (): determines mutant protein sequence from somatic variants and tumor rna.varcode (): predicts variant effects for filtering […]

To access a full list of publications, you will need to upgrade to our premium service.

Vaxrank institution(s)
Department of Genetics and Genomic Sciences at Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Microbiology and Immunology, Medical University of South Carolina, Charleston, SC, USA
Vaxrank funding source(s)
Supported by the Icahn Institute and the Parker Institute for Cancer Immunotherapy.

Vaxrank reviews

star_border star_border star_border star_border star_border
star star star star star

Be the first to review Vaxrank